4.5 Review

The role of neutrophil extracellular traps in cancer progression and metastasis

期刊

SEMINARS IN IMMUNOLOGY
卷 57, 期 -, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2022.101595

关键词

Cancer Immunology; Neutrophil; Metastasis; Innate Immunity; Interleukin-8; Chemotaxis

资金

  1. Clinician Scientist Junior 2, Fonds de recherche du Quebec-Sante (FRQS)
  2. Canada Graduate Scholarships-Master's Award
  3. Bourse de formation de maitrise du Fonds de recherche du Quebec Sante (FRQS)

向作者/读者索取更多资源

NETs play a pro-tumorigenic role in cancer by promoting tumor cell proliferation, immunosuppression, cancer associated thrombosis, and metastasis through their contributions to epithelial-to-mesenchymal transition in tumor cells. Additionally, NETs present in pre-metastatic niches can impact tumor cell recruitment and dormant cell reawakening, favoring metastatic growth. Anti-NET therapies are being explored as a potential treatment option in cancer to synergize with existing anti-cancer therapies.
Neutrophil extracellular traps (NET) are the extracellular release of decondensed chromatin and granules known for their role in host defense against foreign pathogens. However, a novel and predominantly pro-tumorigenic role of NETs in cancer is emerging. Tumors induce NET formation through the secretion of an array of tumor and infection-derived factors. NET deposition favors tumor cell proliferation, immunosuppression and cancer associated thrombosis. Moreover, NETs enhance metastasis by contributing to epithelial-to-mesenchymal transition. A mesenchymal transition in tumor cells potentiates their migratory and invasive abilities. Circulating NETs capture circulating tumor cells and increase vascular permeability, thereby promoting tumor cell intravasation and establishment of micrometastasis. NETs present in pre-metastatic niches serve as cytokines in the recruitment of tumor cells through CCDC25. Through NET-mediated laminin remodelling, dormant cells are reawakened favoring metastatic growth. Moreover, post-operative infection results in high NET deposition and exacerbates post-surgical cancer progression and recurrence. Anti-NET therapies are in use for autoimmune diseases and are now being investigated in the context of cancer. The hope is that anti-NET therapies may synergize with existing anti-cancer therapy to increase rate of response given their multi-faceted interplay in several domains of cancer progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据